Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 23;188(2):303-315.e13.
doi: 10.1016/j.cell.2024.11.008. Epub 2024 Dec 18.

Engineering and structures of Crimean-Congo hemorrhagic fever virus glycoprotein complexes

Affiliations

Engineering and structures of Crimean-Congo hemorrhagic fever virus glycoprotein complexes

Elizabeth McFadden et al. Cell. .

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is a tickborne virus that can cause severe disease in humans with case fatality rates of 10%-40%. Although structures of CCHFV glycoproteins GP38 and Gc have provided insights into viral entry and defined epitopes of neutralizing and protective antibodies, the structure of glycoprotein Gn and its interactions with GP38 and Gc have remained elusive. Here, we use structure-guided protein engineering to produce a stabilized GP38-Gn-Gc heterotrimeric glycoprotein complex (GP38-GnH-DS-Gc). A cryo-electron microscopy (cryo-EM) structure of this complex provides the molecular basis for GP38's association on the viral surface, reveals the structure of Gn, and demonstrates that GP38-Gn restrains the Gc fusion loops in the prefusion conformation, facilitated by an N-linked glycan attached to Gn. Immunization with GP38-GnH-DS-Gc conferred 40% protection against lethal IbAr10200 challenge in mice. These data define the architecture of a GP38-Gn-Gc protomer and provide a template for structure-guided vaccine antigen development.

Keywords: CCHFV; GP38; Gc; Gn; X-ray crystallography; cryo-EM; glycoprotein; prefusion.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests E.M. and J.S.M. are inventors on US patent application no. 63/573,929 (prefusion-stabilized CCHFV GP38-Gn-Gc glycoprotein complex). K.C. holds shares in Integrum Scientific, LLC and Eitr Biologics, Inc.

References

    1. World Health Organization (2020). Crimean-Congo haemorrhagic fever.
    1. Ergonul O (2006). Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6, 203–214. 10.1016/S1473-3099(06)70435-2. - DOI - PMC - PubMed
    1. European Centre for Disease Prevention and Control (2023). The spatial distribution of Crimean-Congo haemorrhagic fever in Europe and neighbouring areas. https://www.ecdc.europa.eu/sites/default/files/documents/crimean-congo-h....
    1. Hawman DW, and Feldmann H (2023). Crimean-Congo haemorrhagic fever virus. Nat Rev Microbiol 21, 463–477. 10.1038/s41579-023-00871-9. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention (2013). Crimean-Congo Hemorrhagic Fever (CCHF).

MeSH terms

LinkOut - more resources